高级检索
当前位置: 首页 > 详情页

Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9

文献详情

资源类型:
机构: [1]Univ South China, Sch Med, Canc Res Inst, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China [2]Univ South China, Affiliated Hosp 1, Dept Radiotherapy, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China [3]Wuhan Univ, Zhongnan Hosp, Dept Resp, Wuhan 430071, Hubei, Peoples R China [4]Peoples Hosp Zhangjiajie City, Dept Resp & Crit Care Med, 192 Guyong Rd, Zhangjiajie 427000, Hunan, Peoples R China
出处:
ISSN:

关键词: CXC receptor 4 epidermal growth factor receptor matrix metallopeptidase 9 non-small cell lung cancer

摘要:
The aim of the present study was to verify whether overexpression of CXC receptor 4 (CXCR4) promotes the invasion and migration of non-small cell lung cancer (NSCLC) via epidermal growth factor receptor (EGFR) and matrix metallopeptidase-9 (MMP-9), and to detect the association between CXCR4, EGFR and MMP-9. The effects of overexpression of CXCR4 on lung cancer cell functions were investigated by migration and invasion assays. Western blotting and zymograph assays were used to analyze the protein expression levels of EGFR and the production of MMP-9, respectively. Immunohistochemistry was applied to analyze the expression of EGFR, CXCR4 and MMP-9 in NSCLC. Statistical analyses were used to detect the associations among EGFR, CXCR4 and MMP-9 in NSCLC. Finally, survival analyses were performed. CXCR4 overexpression enhanced cell motility and invasion. CXCR4 also promoted expression of EGFR and elevated MMP-9 production. CXCR4, EGFR and MMP-9 were highly expressed in NSCLC, and were not identified as associated with age and sex (P>0.05). However, they were associated with tumor differentiation and lymph node metastasis (P<0.05). CXCR4, EGFR and CXCR4 expression were positively associated with one another in NSCLC (P<0.05). In addition, patients with positive expression of CXCR4, EGFR or MMP-9 in tumors exhibited significantly shorter overall survival compared with those with negative expression (P<0.05). In conclusion, CXCR4 overexpression enhanced cell motility and invasion via EGFR and MMP-9. CXCR4, EGFR and MMP-9 were identified as highly expressed in NSCLC, and there was positive correlation among them.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
第一作者:
第一作者机构: [1]Univ South China, Sch Med, Canc Res Inst, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China
通讯作者:
通讯机构: [2]Univ South China, Affiliated Hosp 1, Dept Radiotherapy, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China [3]Wuhan Univ, Zhongnan Hosp, Dept Resp, Wuhan 430071, Hubei, Peoples R China [4]Peoples Hosp Zhangjiajie City, Dept Resp & Crit Care Med, 192 Guyong Rd, Zhangjiajie 427000, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer. [2]Local Therapy for Oligoprogressive Disease in Advanced Staged Non-small Cell Lung Cancer Patients Harboring Epidermal Growth Factor Receptor Mutation [3]非小细胞肺癌患者表皮生长因子受体突变对靶向治疗的疗效影响及生存分析 [4]Clinical Benefit of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors Plus Radiotherapy for Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer: A Retrospective Analysis on Real World Data [5]表皮生长因子受体-酪氨酸激酶抑制剂在治疗非小细胞肺癌方面的研究进展 [6]Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses. [7]Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib [8]A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [9]Antibiotic use is a negative predictor of the efficacy and toxicity of epidermal growth factor receptor-targeted therapy in advanced non-small cell lung cancer. [10]Synergistic effect of canakinumab with epidermal growth factor receptor tyrosine kinase inhibitors versus with chemotherapy for non-small cell lung cancer

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号